WNT ligand biogenesis and trafficking
|
|
|
- C1orf139
- GPR177
- INT1
- INT1L1
- INT4
- IRP
- MEM3
- MG61
- PORC
- PORCN
- PPN
- SNX3
- TMED5
- VPS26
- VPS26A
- VPS29
- VPS35
- WLS
- WNT1
- WNT10A
- WNT10B
- WNT11
- WNT12
- WNT13
- WNT14
- WNT14B
- WNT15
- WNT16
- WNT2
- WNT2B
- WNT3
- WNT3A
- WNT4
- WNT5A
- WNT5B
- WNT6
- WNT7A
- WNT7B
- WNT8A
- WNT8B
- WNT8D
- WNT9A
- WNT9B
|
|
WNT mediated activation of DVL
|
|
|
- CK2A1
- CK2A2
- CK2N
- CSNK1E
- CSNK2A1
- CSNK2A2
- CSNK2B
- DVL1
- DVL2
- DVL3
- G5A
- KIAA0208
- PIP5K1B
- STM7
|
|
WNT5:FZD7-mediated leishmania damping
|
|
|
- CYBA
- DVL1
- DVL2
- DVL3
- FZD7
- JNK1
- JUN
- KIAA0208
- MAPK8
- MOX1
- NOH1
- NOX1
- NOXA1
- NOXO1
- P41NOX
- P51NOX
- PRKM8
- RAC1
- SAPK1
- SAPK1C
- SH3PXD5
- TC25
- WNT5A
|
|
WNT5A-dependent internalization of FZD2, FZD5 and ROR2
|
|
|
- ADTAA
- ADTAB
- ADTB2
- AP17
- AP2A1
- AP2A2
- AP2B1
- AP2M1
- AP2S1
- C2orf31
- CLAPA1
- CLAPA2
- CLAPB1
- CLAPM1
- CLAPS2
- CLH17
- CLTA
- CLTB
- CLTC
- CLTCL2
- FZD2
- FZD5
- HIP9
- HYPJ
- KIAA0034
- KIAA0109
- KIAA0899
- NTRKR1
- NTRKR2
- ROR1
- ROR2
- WNT5A
|
|
WNT5A-dependent internalization of FZD4
|
|
|
- ADTAA
- ADTAB
- ADTB2
- AP17
- AP2A1
- AP2A2
- AP2B1
- AP2M1
- AP2S1
- ARB2
- ARR2
- ARRB2
- CLAPA1
- CLAPA2
- CLAPB1
- CLAPM1
- CLAPS2
- CLH17
- CLTA
- CLTB
- CLTC
- CLTCL2
- DVL2
- FZD4
- HIP9
- HYPJ
- KIAA0034
- KIAA0109
- KIAA0899
- PKCA
- PKCB
- PKCG
- PRKACA
- PRKCA
- PRKCB
- PRKCB1
- PRKCG
- WNT5A
|
|
XAV939 stabilizes AXIN
|
|
|
- PARP5A
- PARP5B
- PARPL
- TANK2
- TIN1
- TINF1
- TNKL
- TNKS
- TNKS1
- TNKS2
|
|
XBP1(S) activates chaperone genes
|
|
|
- 54TM
- ACADVL
- ADD1
- ADDA
- ARF1GAP
- ARFGAP1
- ATP6D
- ATP6V0D1
- C19orf10
- CDA1
- CFP1
- CGBP
- CHL1
- CHLR1
- CLN2
- CTDSP2
- CUL7
- CXXC1
- DCTN1
- DDX11
- DENTT
- DNAJB11
- DNAJB9
- DNAJC3
- EDEM
- EDEM1
- EDJ
- ERD23
- ERJ3
- ERP5
- EXTL
- EXTL1
- EXTL1L
- EXTL2
- EXTL3
- EXTR1
- EXTR2
- FKBP14
- FKBP22
- GFAT
- GFPT
- GFPT1
- GOSR2
- GRP170
- GS27
- GSK3A
- HDGF
- HDJ9
- HMG1L2
- HRD1
- HSPH4
- HYIF1P
- HYOU1
- KDELR3
- KIAA0076
- KIAA0212
- KIAA0218
- KIAA0519
- KIAA0905
- KIAA1027
- KIAA1810
- KLHDC3
- KRG2
- LMN1
- LMNA
- MDG1
- MIZ1
- MYDGF
- NIF2
- ORP150
- OS4
- P5
- P58IPK
- PCCX1
- PDIA5
- PDIA6
- PDIR
- PEAS
- PHF18
- PLA2G4B
- PPP2R5B
- PREB
- PRKRI
- RAMP4
- SCP2
- SEC12
- SEC31A
- SEC31L1
- SERP1
- SHC
- SHC1
- SHCA
- SRPR
- SRPRA
- SRPRB
- SSR1
- STM
- SULT1A3
- SYVN1
- TATDN2
- TLN
- TLN1
- TPP1
- TRAPA
- TSPX
- TSPYL2
- TXNDC7
- VLCAD
- VPATPD
- WFS1
- WIPI1
- WIPI49
- YIF1
- YIF1A
- ZBTB17
- ZNF151
- ZNF60
|
|
Xenobiotics
|
|
|
- AHR
- AHRR
- ARNT
- ARNT2
- BHLHE1
- BHLHE2
- BHLHE76
- BHLHE77
- CYP1A1
- CYP2A13
- CYP2A3
- CYP2A6
- CYP2A7
- CYP2B6
- CYP2C10
- CYP2C18
- CYP2C19
- CYP2C8
- CYP2C9
- CYP2D6
- CYP2DL1
- CYP2E
- CYP2E1
- CYP2F1
- CYP2J2
- CYP2S1
- CYP2W1
- CYP3A3
- CYP3A4
- CYP3A43
- CYP3A5
- CYP3A7
- KIAA0307
- KIAA1234
|
|
YAP1- and WWTR1 (TAZ)-stimulated gene expression
|
|
|
- ANP
- CCN2
- CSX
- CTGF
- GATA4
- HCS24
- HIPK1
- HIPK2
- IGFBP8
- KAT2B
- KIAA0630
- MYAK
- NBAK2
- NKX2-5
- NKX2.5
- NKX2E
- NPPA
- PCAF
- PND
- RTEF1
- TAZ
- TBX5
- TCF13
- TCF13L1
- TEAD1
- TEAD2
- TEAD3
- TEAD4
- TEAD5
- TEF1
- TEF3
- TEF4
- TEF5
- WWTR1
- YAP1
- YAP65
|
|
Z-decay: degradation of maternal mRNAs by zygotically expressed factors
|
|
|
- DDX2A
- DDX2B
- DDX48
- DIS3L2
- EIF4A
- EIF4A1
- EIF4A2
- EIF4A3
- EIF4B
- EIF4E
- EIF4EL1
- EIF4F
- EIF4G
- EIF4G1
- EIF4GI
- FAM6A
- HS2
- KIAA0111
- KIAA0191
- KIAA1711
- PAB1
- PAB2
- PABP
- PABP1
- PABP2
- PABPC1
- PABPC2
- PABPN1
- PAIP1
- TUT4
- TUT7
- ZCCHC11
- ZCCHC6
|
|
ZBP1(DAI) mediated induction of type I IFNs
|
|
|
|
|
Zinc efflux and compartmentalization by the SLC30 family
|
|
|
- SLC30A1
- SLC30A2
- SLC30A3
- SLC30A5
- SLC30A8
- ZNT1
- ZNT2
- ZNT3
- ZNT5
- ZNT8
- ZNTL1
- ZTL1
|
|
Zinc influx into cells by the SLC39 gene family
|
|
|
- BIGM103
- HKE4
- IRT1
- KIAA0062
- KIAA1265
- LIV1
- RING5
- SLC39A1
- SLC39A10
- SLC39A14
- SLC39A2
- SLC39A3
- SLC39A4
- SLC39A5
- SLC39A6
- SLC39A7
- SLC39A8
- ZIP1
- ZIP10
- ZIP14
- ZIP2
- ZIP3
- ZIP4
- ZIP5
- ZIP6
- ZIP8
- ZIRTL
|
|
Zygotic genome activation (ZGA)
|
|
|
- CBP
- CREBBP
- DPPA2
- DPPA4
- DUX10
- DUX4
- DUXA
- DUXB
- EP300
- HS2
- KDM4DL
- KDM4E
- KIAA0191
- KIAA1711
- LEUTX
- P300
- P53
- PESCRG1
- RTEF1
- TCF13L1
- TEAD4
- TEF3
- TP53
- TPRX1
- TPRX2
- TPRXL
- TUT4
- TUT7
- YAP1
- YAP65
- ZCCHC11
- ZCCHC6
- ZNF494
- ZSCAN4
|
|
activated TAK1 mediates p38 MAPK activation
|
|
|
- BLU
- CARD15
- CARD4
- CARDIAK
- CROC1
- CSBP
- CSBP1
- CSBP2
- CSPB1
- FIP3
- IKBKG
- IRAK
- IRAK1
- IRAK2
- KIAA0733
- MAP2K3
- MAP2K6
- MAP3K7
- MAP3K7IP1
- MAP3K7IP2
- MAP3K7IP3
- MAPK11
- MAPK14
- MAPKAPK2
- MAPKAPK3
- MEK3
- MEK6
- MKK3
- MKK6
- MXI2
- NEMO
- NOD1
- NOD2
- PRKM11
- PRKMK3
- PRKMK6
- RICK
- RIP2
- RIPK2
- RNF85
- SAPK2
- SAPK2A
- SAPK2B
- SKK2
- SKK3
- TAB1
- TAB2
- TAB3
- TAK1
- TRAF6
- UBE2N
- UBE2V
- UBE2V1
- UEV1
|
|
alectinib-resistant ALK mutants
|
|
|
|
|
alpha-linolenic acid (ALA) metabolism
|
|
|
- ABCD1
- ACAA
- ACAA1
- ACOT8
- ACSL1
- ACTEIII
- ALD
- CIG30
- EDH17B4
- ELG3
- ELOVL1
- ELOVL2
- ELOVL3
- ELOVL5
- FACL1
- FACL2
- FADS1
- FADS2
- FADSD5
- HSD17B4
- LACS
- LACS1
- LACS2
- PTE1
- PTHIO
- SCP2
- SDR8C1
- SSC1
- SSC2
|
|
betaKlotho-mediated ligand binding
|
|
|
|
|
brigatinib-resistant ALK mutants
|
|
|
|
|
cGMP effects
|
- Calcium-activated potassium channel subunit alpha-1
- Calcium-activated potassium channel subunit beta-1
- Calcium-activated potassium channel subunit beta-2
- Calcium-activated potassium channel subunit beta-3
- Calcium-activated potassium channel subunit beta-4
- Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A
- Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
- High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A
- Inositol 1,4,5-triphosphate receptor associated 1
- Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- cGMP-dependent 3',5'-cyclic phosphodiesterase
- cGMP-dependent protein kinase 2
- cGMP-specific 3',5'-cyclic phosphodiesterase
|
|
- INSP3R1
- IRAG
- IRAG1
- ITPR1
- JAW1L
- KCNMA
- KCNMA1
- KCNMB1
- KCNMB2
- KCNMB3
- KCNMB4
- KCNMBL
- MRVI1
- PDE10A
- PDE11A
- PDE1A
- PDE1B
- PDE2A
- PDE5
- PDE5A
- PDE9A
- PDES1B
- PRKG2
- PRKGR2
- SLO
|
|
cell division
|
|
|
- KIF20A
- KIF23
- KNSL5
- MKLP1
- MKLP2
- PLK
- PLK1
- RAB6KIFL
|
|
ceritinib-resistant ALK mutants
|
|
|
|
|
crenolanib-resistant FLT3 mutants
|
|
|
|
|
crizotinib-resistant ALK mutants
|
|
|
|
|
eNOS activation
|
|
|
- AKT1
- APT1
- CALM
- CALM1
- CAM
- CAM1
- CAV
- CAV1
- CYGB
- DDAH
- DDAH1
- HSP90A
- HSP90AA1
- HSPC1
- HSPCA
- LPL1
- LYPLA1
- NOS3
- PKB
- RAC
- SPR
- STAP
- ZDHHC21
|
|